Crossmark

The impact of imaging time and contrast agent dose on screening for osteoporosis with contrast-enhanced CT

Published Online: 2022-02-10

Published Print: 2022-12

Authors

Woisetschläger, Mischa http://orcid.org/0000-0003-0066-4985
Klintström, Eva

Spångeus, Anna
Funding

Funding for this research was provided by:

Linköping University
License Information

Text and Data Mining valid from 2022-02-10

Version of Record valid from 2022-02-10
More Information

Article History

Received: 23 September 2021

Accepted: 22 December 2021

First Online: 10 February 2022

Declarations

:

: The study was approved by regional ethics committee of the Faculty of Health Sciences, Linköping University (dnr. 2016-43/31 and dnr. 2019-05855). Informed consent was obtained from all patients.

: Not applicable

: The authors declare that they have no competing interests.

Document is current